Baltimore, MD, April 13, 2020 — The American Urological Association (AUA), the world’s leading urology association, is pleased to announce it has entered into a collaboration with Verana Health, a healthcare technology company focused on curating and analyzing health care data to advance medical research and patient care. This new alliance is key to the AUA’s ongoing efforts to advance the highest standards of urologic clinical care through the use of its AUA Quality (AQUA) Registry. This relationship aims to enhance the breadth and depth of the Registry data to facilitate the discovery of leading-edge treatment options and improve outcomes for the millions of people affected by prostate cancer, bladder cancer and other urologic disease.
“With Verana’s expertise enlisted to organize, curate and analyze data from more than six million patients, over 37 million encounters, including 10 percent of the nation’s prostate cancer patients contained within the AQUA Registry, this is an important and paradigm-shifting partnership for our growing registry,” said AUA President, Dr. John Lynch, Professor and Chairman of the MedStar Georgetown University Hospital Department of Urology, Georgetown University School of Medicine Department of Urology and Chief of MedStar's newly formed Regional Urology Service Line. “By collaborating with Verana Health, we are able to truly harness the potential of AQUA Registry data by supporting critical research and facilitating evidence-based medical decisions crucial to better predicting, treating and preventing urologic disease.”
Created in 2014 by urologists, for urologists, the AQUA Registry is a national Qualified Clinical Data Registry designed to help participants measure, federally report and ultimately improve healthcare quality and patient outcomes. Since its launch, the AQUA Registry is fast becoming a definitive resource for informing and advancing urology care within the United States. “This collaboration, along with our existing collaboration with FIGmd, will allow us to build new analytical applications and user interfaces to advance the science of urology, fuel research discoveries and ultimately improve the lives of the patients we serve,” said Chair of the AUA Science and Quality Council, Dr. David Penson, Professor and Chairman, Department of Urology at Vanderbilt University, Hamilton and Howd Chair in Urologic Oncology, and Director, Vanderbilt Center for Surgical Quality and Outcomes Research.
Participation in the AQUA Registry is available to AUA members within the United States. The AQUA Registry helps urology practices simplify federal government reporting and submit performance measures to the Centers for Medicare & Medicaid Services (CMS) and other payers through system optimization.
Learn more about the AQUA Registry and review our Frequently Asked Questions about the AUA and Verana Health collaboration.
About the American Urological Association: Founded in 1902 and headquartered near Baltimore, Maryland, the American Urological Association is a leading advocate for the specialty of urology, and has nearly 22,000 members throughout the world. The AUA is a premier urologic association, providing invaluable support to the urologic community as it pursues its mission of fostering the highest standards of urologic care through education, research and the formulation of health policy.
About Verana Health: Verana Health partners with leading medical associations to transform clinical data into actionable real-world evidence. These partnerships enable Verana to harness the comprehensive data found in qualified clinical data registries and other specialty data sources to accelerate medical research and enhance patient care.